SYRS (Syros Pharmaceuticals) Common Stock: $0.03 Mil (As of Sep. 2024)


SYRS Syros Pharmaceuticals Inc SYRS
12 GF Score
Price $0.00
View Full Analysis

What is Syros Pharmaceuticals Common Stock?

Syros Pharmaceuticals SYRS 12 Common Stock is $0.03 Mil as of Sep. 2024. GuruFocus rates SYRS with a GF Score™ of 12/100.

Syros Pharmaceuticals's quarterly common stock stayed the same from Mar. 2024 ($0.03 Mil) to Jun. 2024 ($0.03 Mil) but then increased from Jun. 2024 ($0.03 Mil) to Sep. 2024 ($0.03 Mil).

Syros Pharmaceuticals's annual common stock increased from Dec. 2021 ($0.01 Mil) to Dec. 2022 ($0.02 Mil) and increased from Dec. 2022 ($0.02 Mil) to Dec. 2023 ($0.03 Mil).

Syros Pharmaceuticals Common Stock Historical Data

* Premium members only.

The historical data trend for Syros Pharmaceuticals's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Syros Pharmaceuticals Common Stock Chart

Syros Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.04 0.06 0.01 0.02 0.03

Syros Pharmaceuticals Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.03 0.03 0.03 0.03
SYRS
12GF Score
Syros Pharmaceuticals Inc SYRS
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Syros Pharmaceuticals Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $0.03 Mil mean?
Syros Pharmaceuticals (SYRS) has a Common Stock of $0.03 Mil as of Sep. 2024. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Syros Pharmaceuticals and its competitors.
Is Syros Pharmaceuticals' Common Stock too high?
Syros Pharmaceuticals' current Common Stock is $0.03 Mil. Overall, Syros Pharmaceuticals has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Syros Pharmaceuticals' Common Stock compare to AFMDQ and BTAX?
Syros Pharmaceuticals' Common Stock of $0.03 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Syros Pharmaceuticals and its competitors. Syros Pharmaceuticals's current Common Stock is $0.03 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Syros Pharmaceuticals stock overvalued right now?
Syros Pharmaceuticals (SYRS) has a current Common Stock of $0.03 Mil. The current Common Stock is $0.03 Mil. Syros Pharmaceuticals' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Syros Pharmaceuticals (SYRS), the current Common Stock is $0.03 Mil as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Syros Pharmaceuticals Business Description

Address 35 CambridgePark Drive, 4th Floor, Cambridge, MA, USA, 02140
Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.
12GF Score

Get the complete analysis for SYRS

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price